OptimizeRx Corp — Director's Dealing 2016

May 31, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2016-05-26

Reporting Person: Hamilton Terrence (SVP of Sales)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-26	Common Stock	C	15913	$1.15	Acquired	380413	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-26	Stock Options	$1	S	122000	Disposed	2016-05-31	Common Stock (122000)	Direct

Footnotes

F1: The Reporting Person has elected to convert 122,000 expiring stock options through a cashless exercise into common stock of the Issuer.